Clinical Trials Directory

Trials / Completed

CompletedNCT02232503

Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia

DIARET SK - Prevalence of Diabetic Retinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in Slovakia

Status
Completed
Phase
Study type
Observational
Enrollment
4,011 (actual)
Sponsor
Novartis Slovakia, s.r.o. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to find out prevalence and individual stages of Diabetic Retinopathy in patients with type 1 and type 2 DM verified based on complex ophthalmologic measurements in Slovak Republic. The outcome of the project will be epidemiology survey, prevalence of diabetic retinopathy (DR) and diabetic macular edema (DME) in relation to type and duration of diabetes mellitus and risk factors. Project will also identify genetic factors linked with the diseases.

Conditions

Interventions

TypeNameDescription
GENETICStudied cohortFor the purpose of DNA isolation prior to genetic analysis of patients two samples of peripheral blood will be taken; first in the volume of 3.5 ml and second in the volume of 9 ml from each patient included into the study.

Timeline

Start date
2015-02-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2014-09-05
Last updated
2016-09-22

Source: ClinicalTrials.gov record NCT02232503. Inclusion in this directory is not an endorsement.